Westhampton Capital’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-4,850
Closed -$482K 113
2019
Q3
$482K Sell
4,850
-140
-3% -$13.3K 0.4% 68
2019
Q2
$461K Buy
+4,990
New +$474K 0.39% 70

Other funds holding CELG

Westhampton Capital's CELG Position: Q4 2019 in Review

Westhampton Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,850 shares — an estimated $482K sold.

Westhampton Capital first reported a position in CELG in Q2 2019 and held it in 2 quarters. The position peaked at $482K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Westhampton Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Westhampton Capital sold 4,850 Celgene Corp shares in Q4 2019, an estimated $482K.
  • Westhampton Capital first reported a position in Celgene Corp in Q2 2019 and held it in 2 quarters.
  • Westhampton Capital's Celgene Corp position peaked at $482K in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Westhampton Capital's 13F filing for Q4 2019, filed 30 Jan 2020.